[1] |
Bertuccio P, Malvezzi M, Carioli G, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma[J]. J Hepatol, 2019, 71(1):104-114.
|
[2] |
Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(9):557-588.
|
[3] |
Mazzaferro V, Gorgen A, Roayaie S, et al. Liver resection and transplantation for intrahepatic cholangiocarcinoma[J]. J Hepatol, 2020, 72(2):364-377.
|
[4] |
Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis[J]. JAMA Surg, 2014, 149(6): 565-574.
|
[5] |
Xie J, Pu X, He J, et al. Survival prediction on intrahepatic cholangiocarcinoma with histomorphological analysis on the whole slide images[J]. Comput Biol Med, 2022(146):105520.
|
[6] |
Zhang XF, Beal EW, Bagante F, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent[J]. Br J Surg, 2018, 105(7):848-856.
|
[7] |
杨发才, 薄志远, 李梦, 等. 第8版AJCC分期系统对肝内胆管癌术后预后评估价值研究[J]. 中国实用外科杂志, 2019, 39(11): 1189-1194.
|
[8] |
Cheng Z, Lei Z, Si A, et al. Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers[J]. HPB, 2019, 21(12):1656-1666.
|
[9] |
Sasaki K, Morioka D, Conci S, et al. The tumor burden score: a new "metro-ticket" prognostic tool for colorectal liver metastases based on tumor size and number of tumors[J]. Ann Surg, 2018, 267(1): 132-141.
|
[10] |
汤朝晖, 田孝东, 魏妙艳, 等. 美国癌症联合委员会胆道恶性肿瘤分期系统(第8版)更新解读[J]. 中国实用外科杂志, 2017, 37(3):248-254.
|
[11] |
El-Diwany R, Pawlik TM, Ejaz A. Intrahepatic Cholangiocarcinoma[J]. Surg Oncol Clin N Am, 2019, 28(4):587-599.
|
[12] |
Uenishi T, Ariizumi S, Aoki T, et al. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery[J]. J Hepatobiliary Pancreat Sci, 2014, 21(7):499-508.
|
[13] |
Kong J, Cao Y, Chai J, et al. Effect of tumor size on long-term survival after resection for solitary intrahepatic cholangiocarcinoma[J]. Front Oncol, 2020(10):559911.
|
[14] |
Tsilimigras DI, Hyer JM, Diaz A, et al. Synergistic impact of alpha-fetoprotein and tumor burden on long-term outcomes following curative-intent resection of hepatocellular carcinoma[J]. Cancers, 2021, 13(4):747.
|
[15] |
Tsilimigras DI, Mehta R, Paredes AZ, et al. Overall tumor burden dictates outcomes for patients undergoing resection of multinodular hepatocellular carcinoma beyond the Milan criteria[J]. Ann Surg, 2020, 272(4):574-581.
|
[16] |
Li H, Liu R, Qiu H, et al. Tumor burden score stratifies prognosis of patients with intrahepatic cholangiocarcinoma after hepatic resection: a retrospective, multi-institutional study[J]. Front Oncol, 2022(12): 829407.
|
[17] |
Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma[J]. Gastroenterology, 2013, 145(6):1215-1229.
|